Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
REVIVES: Vasopressin, Epinephrine, and Steroid in OHCA
NCT06203847Recruiting
- Sponsor
- National Taiwan University Hospital
- Start
- Jul 2024
- Primary completion
- Jul 2026
- Modality
- Peptides, Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, open-label trial of vasopressin and methylprednisolone in cardiac arrest (SCA) (2 arms), sponsored by National Taiwan University Hospital. Primary endpoint: Rate of sustained return of spontaneous circulation at 2 hours. Started Jul 2024; status: recruiting.
02
Drugs
vasopressinmethylprednisolone
03
Conditions
cardiac arrest (SCA)
Beyond the preview
Go deeper on NCT06203847.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06203847.